JP2005531622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005531622A5 JP2005531622A5 JP2004516730A JP2004516730A JP2005531622A5 JP 2005531622 A5 JP2005531622 A5 JP 2005531622A5 JP 2004516730 A JP2004516730 A JP 2004516730A JP 2004516730 A JP2004516730 A JP 2004516730A JP 2005531622 A5 JP2005531622 A5 JP 2005531622A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- components
- administration
- administered
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39258902P | 2002-06-28 | 2002-06-28 | |
| PCT/EP2003/006848 WO2004002485A1 (en) | 2002-06-28 | 2003-06-27 | Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005531622A JP2005531622A (ja) | 2005-10-20 |
| JP2005531622A5 true JP2005531622A5 (https=) | 2006-08-17 |
Family
ID=30000898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004516730A Pending JP2005531622A (ja) | 2002-06-28 | 2003-06-27 | 血管沈静化合物とアルキル化剤を含む腫瘍処置用の組合せ剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7754716B2 (https=) |
| EP (1) | EP1545527A1 (https=) |
| JP (1) | JP2005531622A (https=) |
| CN (1) | CN100355423C (https=) |
| AU (1) | AU2003249895A1 (https=) |
| BR (1) | BR0312283A (https=) |
| CA (1) | CA2490130A1 (https=) |
| WO (1) | WO2004002485A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1922311A2 (en) | 2005-09-09 | 2008-05-21 | Brystol-Myers Squibb Company | Acyclic ikur inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939098A (en) * | 1996-09-19 | 1999-08-17 | Schering Corporation | Cancer treatment with temozolomide |
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| ATE369894T1 (de) * | 2000-11-22 | 2007-09-15 | Novartis Pharma Gmbh | Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität |
| RU2003126913A (ru) * | 2001-02-02 | 2005-03-10 | Шеринг Корпорейшн (US) | 3,4-дизамещенные циклобутен-1,2-дионы, как антагонисты хемокинового рецептора схс |
| GB0111078D0 (en) | 2001-05-04 | 2001-06-27 | Novartis Ag | Organic compounds |
| JP2005505595A (ja) * | 2001-10-12 | 2005-02-24 | シェーリング コーポレイション | Ｃｘｃ−ケモカインレセプターアンタゴニストとしての３，４−二置換マレイミド化合物 |
-
2003
- 2003-06-27 CN CNB038149222A patent/CN100355423C/zh not_active Expired - Fee Related
- 2003-06-27 BR BR0312283-2A patent/BR0312283A/pt not_active IP Right Cessation
- 2003-06-27 CA CA002490130A patent/CA2490130A1/en not_active Abandoned
- 2003-06-27 EP EP03761547A patent/EP1545527A1/en not_active Withdrawn
- 2003-06-27 US US10/518,989 patent/US7754716B2/en not_active Expired - Fee Related
- 2003-06-27 AU AU2003249895A patent/AU2003249895A1/en not_active Abandoned
- 2003-06-27 JP JP2004516730A patent/JP2005531622A/ja active Pending
- 2003-06-27 WO PCT/EP2003/006848 patent/WO2004002485A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016256471B2 (en) | Methods of treating cancer | |
| CN115297862A (zh) | 包含达拉菲尼、erk抑制剂和shp2抑制剂的三重药物组合 | |
| TW202302095A (zh) | 使用ｂｅｔ抑制劑治療骨髓纖維化 | |
| JP2012500180A5 (https=) | ||
| JP2014132009A5 (https=) | ||
| JP6570512B2 (ja) | 新規なＳｔａｔ３阻害剤 | |
| JP2022531906A (ja) | 関節炎性疾患の組み合わせ療法 | |
| EP4322942A1 (en) | Combination comprising everolimus and amcenestrant | |
| US20090312290A1 (en) | Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia | |
| KR20240104138A (ko) | 니로가세스타트를 사용한 조성물 및 치료 | |
| WO2018039022A1 (en) | Compositions comprising pikfyve inhibitors and methods related to inhibition of rank signaling | |
| TW201006823A (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
| NZ550174A (en) | Combinations comprising a vasculostatic compound such as vatalanib and epothilones, and pharmaceutical uses thereof | |
| TWI776451B (zh) | Bcl-2/bcl-xl抑制劑之組合及相關用途 | |
| RU2322238C2 (ru) | Лечение ревматоидного артрита | |
| TW202203928A (zh) | 硫代胺基甲酸酯衍生物ａ２ａ抑制劑的施用方法及調配物 | |
| KR20220124739A (ko) | 암의 치료를 위한 병용 요법 | |
| JP2005531622A5 (https=) | ||
| WO2023204259A1 (ja) | がんの治療又は予防用医薬 | |
| WO2019004465A1 (ja) | ペマフィブラートを含有する医薬 | |
| JPH05310573A (ja) | リウマチ治療薬 | |
| CN100355423C (zh) | 用于治疗肿瘤的包含血管抑制化合物和烷化剂的组合 | |
| EP1485090B1 (en) | Combinations comprising an epothilone derivative and an imidazotetrazinone | |
| US20030139430A1 (en) | Use of organic compounds | |
| WO2024010030A1 (ja) | 血中マイオスタチン低下剤 |